Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma.

Cancer medicine(2023)

引用 1|浏览15
暂无评分
摘要
This combination lacks adequate therapeutic activity for further study, though a subset of patients had prolonged stable disease.
更多
查看译文
关键词
CDK4/6, Ewing sarcoma, ganitumab, IGF-1R, palbociclib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要